24
Document No.: UClRTLl1605 - 20t7723 VMt No: 2 Year: 2017 Ofice; Trhn IPPC Licence No.: POO2U-02 Licence Holder: Avara Shannon Pharrnaceutlcal Services Ltd Facllity Locatlon: Avara Shannon Pharmaceutical Se&= Ltd Rev.No: 1 I Air Emtsfons Comdiance Mpnitorina Emissions bwrt Report Title I 7 AirSGfantlc Ltd., 32 DeGranville Court, Dublin road, Th, Co. Company address Manth I Stack Emfssions Testing Re~ort GommlssiQned by I Avara Shannon Pharmaceutical SeMccts Ltd Facility Name Avara Shannon Pharmaceutical Services Ltd Contact Person Ms. Lourda Molotl~y €PA Licence Number PQQ20-02 Licence Holder Avara Ehanrton PhamaceuElcal Services Ltd Seck Reference Number VEI35 Dates of the Monitoring Campaign 1 stoslaol7 UGIRTLI 1605 - 201 7723 doh Reference Number . Report Written BY Qr. Brian Sheridan Report Approved by I Dr. John Casey -~ Stack Testing Team Dr. Br$n Sheridan, Dr. John Casey Report Date 07/06Y2017 Report Type Test Repart Gomplfance Monitoring Verslon 1 John casey signature of Approver Managing Director For inspection purposes only. Consent of copyright owner required for any other use. EPA Export 20-09-2017:03:20:11

Director - EPA · 2017. 9. 20. · Document No.: lJClffTLileO5 -2017723 Vi& No: 2 Year: mi7 Office; Trim General Information PermanmWemporary Insidel Outsids lPPC Ltmoe No.: PUOBO-02

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • Document No.: UClRTLl1605 - 20t7723 VMt No: 2 Year: 2017 Ofice; Trhn

    IPPC Licence No.: POO2U-02 Licence Holder: Avara Shannon Pharrnaceutlcal Services Ltd

    Facllity Locatlon: Avara Shannon Pharmaceutical Se&= Ltd Rev.No: 1

    I Air Emtsfons Comdiance Mpnitorina Emissions b w r t Report Title I 7

    AirSGfantlc Ltd., 32 DeGranville Court, Dublin road, T h , Co. Company address Manth

    I Stack Emfssions Testing Re~ort GommlssiQned by I Avara Shannon Pharmaceutical SeMccts Ltd Facility Name Avara Shannon Pharmaceutical Services Ltd

    Contact Person Ms. Lourda Molotl~y €PA Licence Number PQQ20-02

    Licence Holder Avara Ehanrton PhamaceuElcal Services Ltd Seck Reference Number VEI35

    Dates of the Monitoring Campaign 1 stoslaol7 UGIRTLI 1605 - 201 7723 doh Reference Number .

    Report Written BY Qr. Brian Sheridan

    Report Approved by I Dr. John Casey -~ Stack Testing Team Dr. Br$n Sheridan, Dr. John Casey

    Report Date 07/06Y2017

    Report Type Test Repart Gomplfance Monitoring Verslon 1

    John casey signature of Approver

    Managing Director

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No . . UCIRTL11605 . 2D-IJ123 Visit No: 2 Year: 201 7 Office: Trfm

    IPPC Licence No . . POOZO-02 Licence Holder: Avara Shannon Pharmaceutical Selvl~es ltcf

    FaFlllty @x+b~. . A%-% Shahno? Phymace@al services Ltd * kv.No: I

    Contents 1 .

    I . Executive Summary ........................................................................................................ .. ...................... 4

    Monitoring Objectives ................................................................................................................ 4 Overall Aim of the monitoring Campaign ........................................................................................ 4 Target Parameters ......................................................................................................................... ~~4 Emission Limit Values ............................................................................. ......,... ................. ...... 4 Reference Conditions ........................................................................................................................ 4 Overall Resuki ................................................................................................................................... 5 Asrreditatim ckta i IS ......................................................................................................................... 5 Monitoring Dafes & Times ............................................................................................................... 6 Process detatls ............................ .....-.. .................................................................. 1.,,11.7 .................. 7 MonitWing. Equipment & Analytical Methods ............................................................................... X Sampling Deviations.. ..................................................................................................................... 10 Reference Documents.. ................................................................................................................. 10 Suitability of sampling location.. ................................................................................................... 11 Stack diagram ................................................................................................................................... 12

    2 . APPENDICES .................................................................................................................................. 13 Appendix I - Monitoring Personn.el & Equipment .................... ....r..ll........rl....I.~I..i.I.. .................. 13

    Stack Emlssions Monitoring Pcrsonne 1 .......................................................................................... 13 Preliminary stack survey calculations ............................................................................................ 14

    Appendix Ill -Individual parameter sampling details and results ........................................ 21 Active Pharmaceutical Ingredient {API) : Sampling details and results .......... Error! Bookmark not

    defined . Active Pha.rmaceutical ingredient (API) Quality Assurance ............. Error1 Bookmark not defined .

    Speclal Requirements ...................................................................................................................... 4

    . .

    II . 111 .

    [V . Appendix II -$tack Dezai15 8i flow characteristics ................................................................. 14

    2 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Oocument Noi: UCIRTLI 1605 - 2017723 Vislt MO: 2 Year: 2017 Ofice: Tdm

    IPPC L b n c e No.: POOZO-112 Llcence Holder: Avara Shannon Pharinaceutbal Servlces Ltd

    Faclllty Looation: Avara Shannon Pharmaaeufical Sewbes Ltd Rev.No: 1

    Oplnluns mdintepmtations expresses her& are ohhide tile scope of Air Scfetttific Limited INAB accreditafidn, fhis test mpmf shall not be repmduced, without the wrlten approval of Air Sdentifia Limited. All sampling and reporting ts completed in

    acctxdancce WM Envlranmental Pmtecfiion Agency Air Guidance Note 2 requtremenfs,

    3 af 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Documen? No.: UCIRTLI 1605 - 2017723 Visit No: 2 Year: eo 1 a Off ice! trtm

    Stack Gas Temperature

    Volume (m?h l)

    lPPC Licence No.: POc-t;rO-oZ Licence Hol&r. Avara Shannwtl Fharrnaceukd Services Ltd

    Faclllty Locatton: h a m Shannon F'harmaceUtfcd %rVlces Ltd Rev. No; 1

    52,000

    1. Executhre Summary

    Oxygen Reference % Temperature K

    Overall Am of the manitoring Campalgn The aim of th8 mnltorlhg campaim was to demonstrate complfancawith a se1 of emission h i l t values as speGifled In the site

    licence.

    No Oxygen Ref

    273.15

    Special Requlrernents

    Moisture ?&

    There were no spedal requirements,

    No

    Target Parameters

    Erniaslon Ltmlt Values

    I Emission Limit Values/ Mass Emlssions Limit Values I rng.m-g I ka.h-' I I API I 0.15 1

    Reference Conditions

    I Reference Conditions I Value I

    1- Tdml Pressure kPa I 101.3 I

    I

    4 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No.; UClRTLl11605 - 2017723 Visit No: 2 Year: 2017 Qffhe: Trim

    Units

    rna.tnV3

    IPPC Licence No.: POO20-02 Licence Holder; Auara Shannon Pharmmacauttcal Services Ltd

    Facillty Location; Avara Shannon Pharmacautical Services Ltd Rev.Na: 1

    Executive Summary

    Resat MU& Limit Campliant Units Result 0.01 0.12 a.is Yes kg.h-' 0.00048

    I Parameter

    m3.k1

    API

    Stack Gas Temperature

    38,680 - 1 52,000 Yes I I Volumetric Row Rat@

    Air Scientific Limited External Analytical Laboratory

    nthar

    Overall Results

    I NAB3 1 9T UKASOGU5

    1 Mass Emlssion Cancentration

    5 of23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No.; UClRTLl1605 - 2D17723

    Year: 2017 Office: Trlm

    visit NQ; 2

    API

    IPPC L i ~ n c ~ No.; POOZO-U2 Licence Holder; Avara Shannon Phamaceuticaf Services Lrd

    Facllity Lbcatlon! Avara Shannon Fhamacauutiml Services Ltd Rw.No: 1

    Executrve Summary

    Run Location Samplingj Sampllng Ssmpltng Duration IO DFA€FIS Time On Time Off (mins.)

    Rub' VE135 16/05/2017 10:47:00 llr49:00 0t:W:W Run 2 - - - - Run 3 - *

    6 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Doournent No.; UClATLI 1605 - 201 7723 Vislt No: 2 Year 20iT Offi~e: Tim

    IPPC Ucenco No.: Paom-02 Llcence Holder: Avara Shannon Pharmactcsutbal Services LM

    FaciUty Location: Avara Shannon Pharmaceutical SstviceS Ltd

    Executive Summary Rev.No: 1

    Process defaits

    Parameter

    I Process status I Normal

    I Continuous or Batch Process I Continuous I Feedstock 1

    ~~

    Filtered Air

    I Abatement System I Yes Abatement SGtarns Running Status 1 ~ Normal

    I Fuel 1 NIA No

    Other htormalion 1 Nohe

    I of23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No.: UMRTLi1805 - 2017723 IPPC Lleence No.: POO20-02 Visit No: 2 Licence Hotder: AV= Shannon Pharmaceutical Semices Ltd 'fear: 201 7 Facility Lacatinn; Awam Shannon Pharmaceulioal SmvIws Ltd Offfcs: Trtm Rev.Na: 1

    9 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Do~ument No.: UClRTtl1605 - 201 7723 Visit No: 2 Year: 2017 Office: Trim

    Parameter

    IPPG Licence NQ,: POMU-02 Licence Holder: Avara Shannon Pharmaceutical Services Ltd

    Facility Location: Anta Shannon Pharmaceutical Services Ltd Rev.No: 1

    Deviation I Standard 10 EN16911 -In accordance wRh MID6911-1

    Standard ID

    Standard ID

    Reference Documents

    Risk Assessment {RA) SOP1 01 1 Site Review {SR) SQP1015

    SOP1 01 5 Sife Specific Plotocal IsSPl

    10 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No.: lJClffTLileO5 -2017723 Vi& No: 2 Year: mi7 Office; Trim

    General Information

    PermanmWemporary

    Insidel Outsids

    lPPC Ltmoe No.: PUOBO-02 Lfcenoe Hofdw: Avara Shannon Pharmaceulicrrl Services Ltd

    Facility Location; Avara Shannon Pharmaceutical SeNlms Ltd Rev.No: I

    Executive Summary

    Value

    Permanent

    Outslde

    Value Irish EPA Technical Guidance Nota AG1 I BS EN 15269 Platform RequSrements Comment

    I Sufficient Workinn area to manipulate probe and measuring instnunenta I yes I Platform has 2 handrails (approx. 0.5m & 1 ..O m high)

    Platform has vertical base boards [approx. 0.25 rn high) Y&3 YO-C

    Platform has chains /self closing gates d top of ladders There are no obstructhns present which hamper insertion Qf sampling

    equipment Safe Access Available

    Easy Amess Waitable

    Sampling Location I Platform Improvement Recommandations

    None

    Yes

    No Yea

    YES

    I BSEN 15259 Homogeneity Test RequiremeM -

    1 :There Is np requirement to perform a BSEN15259 Hornogenity Test oh this stack E.g. Select Option 5: There is no requirement tr, pertorm a BSEN15259 Homogenity Test on thia stack 2: Test results were obtained trom previous Homogeneityled curled nut by ASL 3: Test resuits were obtained from previous Homogeneity test carried out by Altarnatfve contractor U: Othwr: Enter Description

    11 of- 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document Nu,; UCIRTLI I605 - 201 7723 Vkit No; 2 Year; 2017 Office: M m

    IPPC Licence No.: P00213-1)2 Lfcenm Holder: A v m Shannon Pharmaceutical Service3 Ltd

    Facility Lacatlon: Avara Shannon Pharmaceutical Services Ltd Rw,No: 1

    Executive Summary

    Stack diagram

    12 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • DoCUmW NO.: UCIRTLI 1605 - 2017723 Visit NQ: 2 Year; 2017 Office; Trlm

    IPPC Licence No.: POO20-02 Ltcehce Holder: Avara Shannon Pharmaoeutisal Ser~lcw ltd

    Fdtlty Location: Avara Eihhannon Pharmaceutical SeFvfcea Ltd %V.NQ: 1

    APPENDICES

    U. Appendlx / Monitoring Personnel i% Equipment

    Stack Emissions Monitoring PersonneI

    13 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • DOCUhlBht NO,: UClRTLl I605 - 201 7723 Vtslt No: 2 Year: 2017 Office; Trim

    Sample P ~ l t Size

    Initld Pitot Leak Check

    Ffnal Pitot Leak Check Oriehtatlnn of Duct

    PbtTube Gp

    Number of Lines Available

    Number of Lines Used

    IPPC Licence No.: POO20-02 Licence Holdet: Pivarh Shannon Phamtaoautic~ldces Ltd

    Fadlity LocaUon: A w a Shannon Pharmaceutical Servtce:: Ltd Rev.No: 1

    1 25

    Pa 780

    790 Pa

    Vertical

    I3.998

    2

    2

    mrn

    Pranminary stack survey calcu!ations

    14 of 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • 16 O f 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • 19 of23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Where KpI =Pbt lube calbrafion W k i e n l

    Compressibilliy cosreaton lactor, ammed ai awnstant 0 . m

    20 of 23

    a.@ 039&

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • c

    PitotTube Leak Check Positjva Pressure

    Neqatfve Pressure

    Document MO.: UGlRTLl1605 - 2017723 Vislt No: 2 Year: 2017 Offlce: Trim

    Result

    Pass Pass

    IPPG licence No.: POMO-02 IJcenoe Holder: Avara Shannon Pharrnaoeutical Services Ltd

    Facility Location: Awra Shannon Pharmaceuticd ServIws Ltd Rev.No: 1

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • DOCMIEII~ No.: UClRTLll605 - 2P17723 Vfdt No: e Year: 2017

    IPPC Licence No.: POO2Q-02 Lfcenoe Haldqr; Avara Shannon Pharmaceutlcal bwicw Ltd

    Facility Locatian: Avera Shannon Pharhmeutioal Services Ltd

    Blank (Filter and Front Wash Combined)

    Sample I (Filter and Front Combined)

    Volume of Air Sampled

    Blank Result

    Sample Result

    Emissfon Limit Value

    co,oo2 ms 0.046 rng

    1.30 ma a.uoi5 ma.m3

    O.lH23 rnn.m*

    0.15 rng.m+

    Standard R a% Blank as Percentage of ELV $0 Requirement ELV

    Isaklnetlc Criterion Corn~l~ar~ce

    lsukinetic Variation

    Atlowab[e IsoKineflc Range

    Is0 Kineftcity r4icceptable

    96 0

    Ya 951 15

    YES - -

    22 af 23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Document No.: UCIRTLI 1605-2017723 Visit MO: 2 Year: 2017 oftiw Trtm

    Stack ID

    IPPC Licence No.: POO20-02 Licenca Holder; Avara Shannon Pharmaceutical Services Ltd

    SaclUty Looaffan: Avara Shannon Pharmacautical Services Ltd RwNo: 1

    VEI 35

    BP1 Quality Assurance

    Filler Housing

    filter, 8mm Filter Size and

    Number of Sampling lines

    Number of Sampling Points

    23 of23

    Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

  • Fo

    r ins

    pecti

    on pu

    rpos

    es on

    ly.

    Cons

    ent o

    f cop

    yrigh

    t own

    er req

    uired

    for a

    ny ot

    her u

    se.

    EPA Export 20-09-2017:03:20:11

    Executive SummaryMonitoring ObjectivesOverall Aim of the monitoring CampaignSpeclal RequirementsEmission Limit ValuesReference ConditionsOverall ResukiAsrreditatim ckta i ISMonitoring Dafes & TimesProcess detatls 1.,,11.7Sampling DeviationsReference DocumentsSuitability of sampling locationStack diagram

    2 APPENDICESIIStack Emlssions Monitoring Pcrsonne 1

    Appendix II -$tack Dezai15 8i flow characteristicsPreliminary stack survey calculations

    [VAppendix Ill -Individual parameter sampling details and results2 of